Point72 Hong Kong Ltd lifted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 319.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,187 shares of the company's stock after purchasing an additional 10,043 shares during the quarter. Point72 Hong Kong Ltd's holdings in Doximity were worth $704,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in DOCS. QSV Equity Investors LLC grew its holdings in Doximity by 0.3% during the 4th quarter. QSV Equity Investors LLC now owns 60,763 shares of the company's stock worth $3,244,000 after acquiring an additional 186 shares during the last quarter. Handelsbanken Fonder AB boosted its stake in shares of Doximity by 0.7% in the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company's stock valued at $1,586,000 after purchasing an additional 200 shares during the last quarter. UMB Bank n.a. boosted its stake in shares of Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. Fielder Capital Group LLC boosted its stake in shares of Doximity by 4.5% in the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company's stock valued at $293,000 after purchasing an additional 235 shares during the last quarter. Finally, Larson Financial Group LLC boosted its stake in shares of Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after purchasing an additional 250 shares during the last quarter. 87.19% of the stock is owned by institutional investors.
Doximity Stock Down 1.4%
DOCS traded down $0.76 during trading hours on Tuesday, hitting $53.01. The stock had a trading volume of 4,198,154 shares, compared to its average volume of 2,086,864. Doximity, Inc. has a 1 year low of $25.00 and a 1 year high of $85.21. The company's fifty day simple moving average is $57.19 and its 200 day simple moving average is $58.03. The stock has a market cap of $9.90 billion, a PE ratio of 53.01, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41.
Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the prior year, the business earned $0.25 earnings per share. Doximity's quarterly revenue was up 17.1% compared to the same quarter last year. As a group, equities analysts expect that Doximity, Inc. will post 0.99 EPS for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the stock. KeyCorp reduced their price objective on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Robert W. Baird reduced their price objective on shares of Doximity from $87.00 to $65.00 and set an "outperform" rating on the stock in a research note on Tuesday. Leerink Partners raised shares of Doximity from a "market perform" rating to an "outperform" rating and upped their price objective for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Mizuho reduced their price objective on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a research note on Friday. Finally, Morgan Stanley reduced their price objective on shares of Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Doximity has a consensus rating of "Moderate Buy" and a consensus price target of $62.89.
View Our Latest Analysis on Doximity
Insider Activity
In other Doximity news, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the transaction, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at approximately $20,440,552.95. This trade represents a 11.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the transaction, the director now directly owns 16,618 shares in the company, valued at approximately $946,062.74. The trade was a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is owned by company insiders.
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Articles

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.